| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 141, 487-496, Copyright © 1992 by American Society for Investigative Pathology
REGULAR ARTICLES |
CL Webb, NM Nguyen, FJ Schoen and RJ Levy
Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor 48109-0576.
Aortic allograft conduits and valves frequently undergo calcific degeneration. To study this problem, a rat subdermal model of nonvalved aortic wall allograft calcification was characterized, and experimental studies were carried out to test the hypothesis that aortic allograft preincubation in either amino-propanehydroxydiphosphonate (APDP) or AlCl3 would inhibit calcification in a rat subdermal model. Fresh thoracic aortas were harvested under sterile conditions from male Sprague-Dawley rats (350-400 g). APDP aortas were preincubated immediately in either 4 x 10(-3) mol/l, 4 x 10(-4) mol/l, or 4 x 10(-5) mol/l [14C] APDP (37 degrees C, pH 7.4) and controls were incubated in 0.05 mol/l HEPES buffer (pH 7.4, 37 degrees C, 30 min). Al3+ aortas were preincubated in either 10(-1) mol/l, 10(-2) mol/l, or 10(-3) mol/l AlCl3. Pretreated aortas were next implanted subdermally in weanling rats (3-week-old, male, Sprague-Dawley, 50-60 g) and retrieved after 21 days. Control explants retrieved at intervals up to 21 days demonstrated progressive calcification with bulk aortic allograft Ca2+ levels increasing from a preimplant value of 0.8 +/- 0.1 micrograms/mg to 129.8 +/- 12.9 micrograms/mg by 21 days. Light microscopy revealed that much of the calcium deposition was associated with elastin. Calcification was significantly inhibited in the 4 x 10(-3) mol/l and 4 x 10(-4) mol/l APDP preincubated groups was observed (Ca2+ = 0.70 +/- 0.15 micrograms/mg, 36.6 +/- 19.8 micrograms/mg, respectively versus 117.2 +/- 24.3 micrograms/mg, control). Inhibition of calcification in the groups preincubated in the two most concentrated AlCl3 solutions (Ca2+ = 13.9 +/- 4.9 micrograms/mg [10(-2) mol/l AlCl3], 36.6 +/- 7.1 micrograms/mg [10(-3) mol/l AlCl3], 171.0 +/- 13.2 micrograms/mg [control]) was also demonstrated. No adverse effects of either pretreatment, APDP, or AlCl3 were noted on bone or overall somatic growth.
This article has been cited by other articles:
 |
|
 |
|
  A. Saito, N. Motomura, K. Kakimi, K. Narui, N. Noguchi, M. Sasatsu, K. Kubo, Y. Koezuka, D. Takai, S. Ueha, et al. Vascular allografts are resistant to methicillin-resistant Staphylococcus aureus through indoleamine 2,3-dioxygenase in a murine model J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 159 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Clark, M. F. Ogle, P. Ashworth, R. W. Bianco, and R. J. Levy Prevention of Calcification of Bioprosthetic Heart Valve Cusp and Aortic Wall With Ethanol and Aluminum Chloride Ann. Thorac. Surg., March 1, 2005; 79(3): 897 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Ogle, S. J. Kelly, R. W. Bianco, and R. J. Levy Calcification resistance with aluminum-ethanol treated porcine aortic valve bioprostheses in juvenile sheep Ann. Thorac. Surg., April 1, 2003; 75(4): 1267 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Vyavahare, M. Ogle, F. J. Schoen, and R. J. Levy Elastin Calcification and its Prevention with Aluminum Chloride Pretreatment Am. J. Pathol., September 1, 1999; 155(3): 973 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Schoen, D. Hirsch, R. W. Bianco, and R. J. Levy Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 880 - 887. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
